These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33473063)

  • 41. SARC-F scores can predict health status and daily activity in patients with idiopathic pulmonary fibrosis.
    Ohkubo H; Fujita K; Nakano A; Amakusa Y; Mori Y; Fukumitsu K; Fukuda S; Kanemitsu Y; Uemura T; Tajiri T; Maeno K; Ito Y; Oguri T; Ozawa Y; Murase T; Niimi A
    J Thorac Dis; 2022 Nov; 14(11):4309-4318. PubMed ID: 36524076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical significance of pectoralis muscle strength in elderly patients with idiopathic pulmonary fibrosis.
    Durdu H; Yurdalan SU; Ozmen I
    Sarcoidosis Vasc Diffuse Lung Dis; 2022; 39(1):e2022009. PubMed ID: 35494168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Evaluation of the relationship between the parameters of peripheral skeletal and respiratory muscles in patients with chronic obstructive pulmonary disease].
    Suleymanova AK; Baranova IA
    Ter Arkh; 2020 Apr; 92(3):36-41. PubMed ID: 32598791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reference values of skeletal muscle area for diagnosis of sarcopenia using chest computed tomography in Asian general population.
    Moon SW; Lee SH; Woo A; Leem AY; Lee SH; Chung KS; Kim EY; Jung JY; Kang YA; Park MS; Kim YS; Kim CO; Kim SY
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):955-965. PubMed ID: 35170229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry.
    Case AH; Hellkamp AS; Neely ML; Bender S; Dilling DF; Gulati M; Hotchkin DL; Huie TJ; Lancaster L; Snyder LD; Conoscenti CS; Palmer SM
    Ann Am Thorac Soc; 2020 Jun; 17(6):699-705. PubMed ID: 32040340
    [No Abstract]   [Full Text] [Related]  

  • 46. Phenotypic characteristics associated with slow gait speed in idiopathic pulmonary fibrosis.
    Nolan CM; Maddocks M; Maher TM; Canavan JL; Jones SE; Barker RE; Patel S; Jacob J; Cullinan P; Man WD
    Respirology; 2018 May; 23(5):498-506. PubMed ID: 29139195
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction.
    Han MK; Bach DS; Hagan PG; Yow E; Flaherty KR; Toews GB; Anstrom KJ; Martinez FJ;
    Chest; 2013 Jun; 143(6):1699-1708. PubMed ID: 23732584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improvement in Patient-Reported Outcomes and Forced Vital Capacity during Nintedanib Treatment of Idiopathic Pulmonary Fibrosis.
    Takeda T; Takeuchi M; Saitoh M; Takeda S
    Tohoku J Exp Med; 2018 Jun; 245(2):107-114. PubMed ID: 29925700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials.
    Kreuter M; Wuyts WA; Wijsenbeek M; Bajwah S; Maher TM; Stowasser S; Male N; Stansen W; Schoof N; Orsatti L; Swigris J
    Respir Res; 2020 Jan; 21(1):36. PubMed ID: 32000772
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation of the King's Brief Interstitial Lung Disease questionnaire in Idiopathic Pulmonary Fibrosis.
    Prior TS; Hilberg O; Shaker SB; Davidsen JR; Hoyer N; Birring SS; Bendstrup E
    BMC Pulm Med; 2019 Dec; 19(1):255. PubMed ID: 31856786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigation of respiratory muscle strength and its influence on exercise capacity and quality of life in patients with idiopathic pulmonary fibrosis.
    Pehlivan E; Zeren M; Niksarlıoğlu EY; Karaahmetoğlu FS; Özcan ZB; Balcı A; Demirkol B; Çetinkaya E
    Sarcoidosis Vasc Diffuse Lung Dis; 2024 Jun; 41(2):e2024028. PubMed ID: 38940715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis.
    Lee YJ; Choi SM; Lee YJ; Cho YJ; Yoon HI; Lee JH; Lee CT; Park JS
    PLoS One; 2017; 12(9):e0184300. PubMed ID: 28892504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dyspnea Associates With a Widely Impaired Quality of Life in Idiopathic Pulmonary Fibrosis Patients: A Longitudinal Study Using 15D.
    Rautajoki T; Lehto JT; Sutinen E; Bergman P; Sintonen H; Rajala K; Mäkelä K; Hollmen M; Saarto T; Myllärniemi M
    J Palliat Med; 2023 Oct; 26(10):1357-1364. PubMed ID: 37366772
    [No Abstract]   [Full Text] [Related]  

  • 54. Physical activity and quality of life improvements of patients with idiopathic pulmonary fibrosis completing a pulmonary rehabilitation program.
    Gaunaurd IA; Gómez-Marín OW; Ramos CF; Sol CM; Cohen MI; Cahalin LP; Cardenas DD; Jackson RM
    Respir Care; 2014 Dec; 59(12):1872-9. PubMed ID: 25185149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease].
    Tan M; Jian W; Liang Q; Li S; Cui H
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1119-1124. PubMed ID: 34308866
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between the thickness of erector spinae muscles and mortality in patients with pulmonary tuberculosis.
    Shimoda M; Yoshiyama T; Tanaka Y; Morimoto K; Okumura M; Kodama T; Nakajima K; Yoshimori K; Ohta K
    Respir Investig; 2023 Jul; 61(4):511-519. PubMed ID: 37267852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis.
    Takei R; Matsuda T; Fukihara J; Sasano H; Yamano Y; Yokoyama T; Kataoka K; Kimura T; Suzuki A; Furukawa T; Fukuoka J; Johkoh T; Kondoh Y
    Front Med (Lausanne); 2023; 10():1067149. PubMed ID: 37457568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased Appendicular Skeletal Muscle Mass is Associated with Poor Outcomes after ST-Segment Elevation Myocardial Infarction.
    Sato R; Akiyama E; Konishi M; Matsuzawa Y; Suzuki H; Kawashima C; Kimura Y; Okada K; Maejima N; Iwahashi N; Hibi K; Kosuge M; Ebina T; von Haehling S; Anker SD; Tamura K; Kimura K
    J Atheroscler Thromb; 2020 Dec; 27(12):1278-1287. PubMed ID: 32132340
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Benefits of physical training in patients with idiopathic or end-stage sarcoidosis-related pulmonary fibrosis: a pilot study.
    Strookappe B; Elfferich M; Swigris J; Verschoof A; Veschakelen J; Knevel T; Drent M
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):43-52. PubMed ID: 26237355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The St. George's Respiratory Questionnaire as a prognostic factor in IPF.
    Furukawa T; Taniguchi H; Ando M; Kondoh Y; Kataoka K; Nishiyama O; Johkoh T; Fukuoka J; Sakamoto K; Hasegawa Y
    Respir Res; 2017 Jan; 18(1):18. PubMed ID: 28095852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.